Related Experiment Video
Updated: Aug 18, 2026

An Improved and High Throughput Respiratory Syncytial Virus (RSV) Micro-neutralization Assay
Published on: January 26, 2019
Estimating current susceptibility to measles in Australia following sustained measles elimination
Zoë Croker1, Angus McLure2, Stephen Lambert3
1National Centre for Immunisation Research and Surveillance, The Children's Hospital at Westmead, NSW 2145, Australia; Australian National University, National Centre for Epidemiology and Population Health, ACT 2600, Australia.
Objective:
This study estimates Australia's measles susceptibility across all age groups. To our knowledge, this study is the first internationally to combine multiple consecutive serosurvey and population immunisation register data.
Methods:
We estimated age-specific measles susceptibility in 2019 using data from nationally representative seroprevalence surveys for people born between 1920 and 1960 (infection-acquired immunity) and those born 1961-1999 (infection/vaccine-acquired immunity). For people born 2000-2018 (vaccine-acquired immunity only), we estimated measles susceptibility from coverage of one or two doses of measles-containing vaccine from the Australian Immunisation Register and presumed vaccine effectiveness, adjusting for 0·04% waning of protection per year.
Results:
Susceptibility increased from less than 1% across those born 1920-1960 to 11% for the 1993-1995 cohort, and ranged from 7-14% for those born 2000-2015. We estimated that 1.7 million Australians (6·7%) were susceptible to measles in 2019 (95%UI: 1·3-3·2 million). Among notifications of measles infection between 2008 and 2022, people aged 15-35 years at time of notification accounted for 50%.
Conclusions:
Despite sustained high two-dose measles vaccine coverage, Australia's overall population-level measles immunity is at the lower end of the World Health Organization estimated herd protection threshold range (93-95%).
Implications For Public Health:
Our estimates provide baseline data to inform vaccination activities to address immunity gaps in older age groups, particularly those likely to travel internationally.
More Related Videos
09:08Developing a Salivary Antibody Multiplex Immunoassay to Measure Human Exposure to Environmental Pathogens
Published on: September 12, 2016
09:31Fluorescence-based Neuraminidase Inhibition Assay to Assess the Susceptibility of Influenza Viruses to The Neuraminidase Inhibitor Class of Antivirals
Published on: April 15, 2017
Related Concept Videos
Vaccinations
Smallpox
Malaria
Infectious Diseases and Their Occurrence
Steps in Outbreak Investigation
Poliomyelitis